Effectiveness of Ayurvedic Formulation Patanjali Aurogrit in subjects with Breast Cancer.
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/10/058318
- Lead Sponsor
- Patanjali Research Foundation governed by Patanjali Research Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects diagnosed with Breast Cancer.
Subjects Aged 18 years and above.
Willing to participate and give consent for the study.
Capability for complete compliance and completion of follow-up
Exclusion Criteria
Male subjects with breast cancer.
Subjects diagnosed with Metastatic breast cancer.
Subjects with other co-morbidities, such as CVD, liver abnormalities, and HIV.
Assessment by the investigator as being unable or unwilling to comply with the requirements of the protocol.
The subjects with complications and requiring surgical interventions.
Pregnant or Lactating women and women intenting to become pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluating the Efficacy and changesin clinical lab parameters, radiological imaging and efficacy outcomesof Aurogrit in subjects diagnosed with Breast cancerTimepoint: Baseline, Day 30, Day 60 and Day 90
- Secondary Outcome Measures
Name Time Method Incidence of treatment-related symptoms and assessment of health-related quality of life (HRQOL) as measured using the European Organization for the Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) questionnaire, DASS-21, BR23 and BRECON 23 questionnaireTimepoint: Baseline, Day 30, Day 60 and Day 90